Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Lopez

Showing results (281-290 of 285) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 285 results.
Scientific Reports|May 5, 2023
SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in BrazilFelipe Gomes Naveca, Valdinete Alves Nascimento, Fernanda Nascimento, et al.
Viruses|January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 LaboratoriesPolina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Vaccine|September 4, 2023
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster doseMaria da Penha Gomes Gouvea, Ketty Lysie Libardi Lira Machado, Yasmin Gurtler Pinheiro de Oliveira, et al.
Vaccines|November 26, 2025
Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana StudyNésio Fernandes de Medeiros-Junior, Maria da Penha Gomes Gouvea, Luiz Antônio Bastos Camacho, et al.
Nature Genetics|December 30, 2025
Unearthing soil biodiversity through collaborative genomic research and education, Tristen Alberts, Claude F Albritton, et al.
Pageof 29

Showing results (281-290 of 285) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 285 results.
Scientific Reports|May 5, 2023
SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in BrazilFelipe Gomes Naveca, Valdinete Alves Nascimento, Fernanda Nascimento, et al.
Viruses|January 8, 2025
A Global Collaborative Comparison of SARS-CoV-2 Antigenicity Across 15 LaboratoriesPolina Brangel, Sina Tureli, Barbara Mühlemann, et al.
Vaccine|September 4, 2023
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster doseMaria da Penha Gomes Gouvea, Ketty Lysie Libardi Lira Machado, Yasmin Gurtler Pinheiro de Oliveira, et al.
Vaccines|November 26, 2025
Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana StudyNésio Fernandes de Medeiros-Junior, Maria da Penha Gomes Gouvea, Luiz Antônio Bastos Camacho, et al.
Nature Genetics|December 30, 2025
Unearthing soil biodiversity through collaborative genomic research and education, Tristen Alberts, Claude F Albritton, et al.
Pageof 29